Alex Kalombaris has been named an honored member in healthcare by Princeton Premier.

Oct. 15, 2008 - PRLog -- Alex Kalombaris is the head of global research and development communications for AstraZeneca, a leading pharmaceutical company that provides new medicines that are designed to improve the health and quality of life of patients around the world; medicines that are innovative, effective and offer benefits like reduced side effects.  Alex has been with AstraZeneca since 2006 and is responsible for overseeing the operations that enable life-changing medicines to reach patients as quickly, safely and efficiently as possible.  He is an accomplished and skillful scientist who holds a B.Sc. in biochemical engineering from Imperial College in London and has more than two decades of experience working within the field of medical research.  Alex is a member of the International Association of Business Communicators and has contributed his knowledge through various conferences and public speaking engagements.  He is equally committed to the community and maintains an active philanthropic profile, donating to the Red Cross and Terrance Higgins Trust.  In his spare time, Alex enjoys reading the Economist, kickboxing, cooking and travel.  

In recognition of an exceptional career as head of global research and development communications for AstraZeneca, Alex Kalombaris is being included in the 2008/2009 Princeton Premier Registry alongside the most prominent business leaders and professionals of every industry, from around the globe.

# # #

Princeton Premier is a publisher of an exclusive registry of business leaders & professionals making an impact in industry and community. The online network is a large interactive community where members use the web based service to meet business goals.